AXGN – AxoGen, Inc.

AxoGen, Inc.

AXGN

$50.89

Name : AxoGen, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $3,039,696,128.00

EPSttm : -0.63

AxoGen, Inc.

$50.89

0.49%

$0.25

AXGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.79

Margin Of Safety %

-35

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.09

EPS Last/This Y

0.26

EPS This/Next Y

0.15

Price

50.86

Target Price

59.09

Analyst Recom

1.33

Performance Q

2.46

Upside

-144.7%

Beta

1.15

Ticker: AXGN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	AXGN	37.11	0.03	0.11	30891
2026-10-13	AXGN	36.19	0.03	0.02	30956
2026-10-14	AXGN	35.14	0.03	0.00	31107
2026-10-15	AXGN	35.63	0.03	0.00	31115
2026-10-16	AXGN	34.62	0.03	0.01	31092
2026-10-19	AXGN	35.22	0.03	1.06	22905
2026-10-20	AXGN	36.16	0.03	0.25	22989
2026-10-21	AXGN	36.51	0.05	0.02	24898
2026-10-22	AXGN	36.71	0.05	13.00	24995
2026-10-23	AXGN	38.07	0.05	0.02	25006
2026-10-26	AXGN	38.06	0.05	2.00	26534
2026-10-27	AXGN	37.41	0.05	0.01	26609
2026-10-28	AXGN	49.09	0.04	0.03	30756
2026-10-29	AXGN	49.6	0.04	0.10	41821
2026-10-30	AXGN	49.38	0.04	0.01	40649
2026-11-02	AXGN	49.81	0.04	0.16	38761
2026-11-03	AXGN	49.54	0.04	0.70	39081
2026-11-04	AXGN	51.23	0.04	0.01	39093
2026-11-05	AXGN	48.75	0.04	0.13	37905
2026-11-06	AXGN	49.77	0.04	0.50	37824
2026-11-09	AXGN	50.67	0.04	0.04	37826
2026-11-10	AXGN	50.92	0.04	0.00	37833
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	AXGN	37.11	8.0	-	0.47
2026-10-13	AXGN	36.13	8.0	-	0.47
2026-10-14	AXGN	35.13	9.7	-	0.48
2026-10-15	AXGN	35.62	9.7	-	0.48
2026-10-16	AXGN	34.65	9.7	-	0.48
2026-10-19	AXGN	35.23	9.7	-	0.48
2026-10-20	AXGN	35.23	9.7	-	0.48
2026-10-21	AXGN	36.16	11.7	-	0.48
2026-10-22	AXGN	36.71	11.7	-	0.48
2026-10-23	AXGN	38.06	11.7	-	0.48
2026-10-26	AXGN	38.01	11.7	-	0.48
2026-10-27	AXGN	37.34	9.4	-	0.47
2026-10-28	AXGN	49.21	9.4	-	0.47
2026-10-29	AXGN	49.57	91.2	-	0.47
2026-10-30	AXGN	49.37	91.2	-	0.47
2026-11-02	AXGN	49.85	114.4	-	0.55
2026-11-03	AXGN	49.51	108.1	-	0.55
2026-11-04	AXGN	51.33	108.1	-	0.55
2026-11-05	AXGN	48.71	108.1	-	0.55
2026-11-06	AXGN	49.90	108.1	-	0.55
2026-11-09	AXGN	50.62	108.1	-	0.55
2026-11-10	AXGN	50.86	108.1	-	0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	AXGN	-8.67	8.47	8.21
2026-10-13	AXGN	-8.67	8.47	8.21
2026-10-14	AXGN	-8.67	8.47	8.21
2026-10-15	AXGN	-8.67	8.47	8.21
2026-10-16	AXGN	-8.67	8.47	8.21
2026-10-19	AXGN	-8.67	7.85	8.21
2026-10-20	AXGN	-8.67	7.85	8.21
2026-10-21	AXGN	-8.67	7.85	8.21
2026-10-22	AXGN	-8.67	7.85	8.21
2026-10-23	AXGN	-8.67	7.85	8.21
2026-10-26	AXGN	-8.67	7.04	8.21
2026-10-27	AXGN	-8.67	7.04	8.95
2026-10-28	AXGN	-8.67	7.04	8.95
2026-10-29	AXGN	-8.67	7.04	8.95
2026-10-30	AXGN	-8.67	7.04	8.95
2026-11-02	AXGN	-8.53	7.06	8.79
2026-11-03	AXGN	-8.53	7.06	8.79
2026-11-05	AXGN	-8.53	7.06	8.79
2026-11-06	AXGN	-8.53	7.06	8.79
2026-11-09	AXGN	-6.41	5.87	8.79
2026-11-10	AXGN	-6.41	5.87	8.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

0.15

Avg. EPS Est. Next Quarter

0.13

Insider Transactions

-6.41

Institutional Transactions

5.87

Beta

1.15

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

33.26

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.9

Max Drawdown 5-Year %

-73.1

Target Price

59.09

P/E

Forward P/E

72.12

PEG

1.45

P/S

11.39

P/B

6.13

P/Free Cash Flow

137.92

EPS

-0.65

Average EPS Est. Cur. Y

0.55

EPS Next Y. (Est.)

0.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.96

Relative Volume

0.72

Return on Equity vs Sector %

-32.7

Return on Equity vs Industry %

-17.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

◆ AXGN Healthcare

$50.89

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

6/25

Volume

9/15

Valuation

9/20

TP/AR

2/10

Options

7/10

RSI

69.5

Range 1M

89.3%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

9/25

Growth

29/30

Estimates

2/20

Inst/Vol

7/15

Options

8/10

EPS Yr

91%

EPS NY

27.4%

52W%

92.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -32.8% upside

Quality

6/30

Valuation

2/30

Growth

21/25

Stability

8/10

LT Trend

4/5

Upside

-32.8%

Quality

MoS

-35%

AXGN — P/E HistoricalMedical Devices

AxoGen, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 622

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

AXGN

Latest News

—

Caricamento notizie per AXGN…

stock quote shares AXGN – AxoGen, Inc. Stock Price stock today

news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AXGN – AxoGen, Inc. yahoo finance google finance

stock history AXGN – AxoGen, Inc. invest stock market

stock prices AXGN premarket after hours

ticker AXGN fair value insiders trading

AXGN – AxoGen, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AXGN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y